Viveve Medical, Inc. (VIVE) News
Track canonical SquawkNews coverage tagged to VIVE, Viveve Medical, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Vivesto Says Topline Results For Paccal Vet 'Positive'
Vivesto AB OMXSTO:VIVE
NEWS | Sep 15, 2026, 11:55 AM UTC
L
Vivesto AB Reports Positive Topline Data for Paccal Vet in Dogs
Vivesto reported positive topline results in 26 dogs with Stage I—II splenic hemangiosarcoma post-splenectomy, showing median overall survival of 135 days with Paccal Vet. Data support moving to a pivotal study; four dog
NEWS | Sep 15, 2026, 11:45 AM UTC
L
Vivesto’s positive dog topline results support continued development and strengthen partnering prospects for Paccal Vet
Solna, Sweden, September 15, 2026 — Vivesto AB, an oncology-focused development company, today announced positive topline results from its open label clinical pilot study evaluating Paccal Vet in dogs with splenic hemang
NEWS | Sep 15, 2026, 11:45 AM UTC